LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Clarithromycin / Clarithromycin 14-Hydroxy
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Antiinflamatory, Antibacterial, Antimalarial
Diltiazem / Diltiazem Desacetyl / Diltiazem
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Ezetemibe (Free) / Ezetemibe Glucouronide
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Mycophenolic Acid / Mycophenolate Mofetil
Anti-obesity (gastric and pancreatic lipase
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Anti-obesity (gastric and pancreatic lipase
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF DIFFICULT BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Antiinflamatory, Antibacterial, Antimalarial
Mycophenolic Acid / Mycophenolate Mofetil
Anti-obesity (gastric and pancreatic lipase
inhibitor)Anti-obesity (gastric and pancreatic lipase
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF DIFFICULT BIOANALYTICAL METHODS AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
LIST OF BIOANALYTICAL METHODS UNDER DEVELOPMENT AT FORTIS CLINICAL RESEARCH LIMITED
LLOQ (per mL) Instrument Theraputic Classification
Facility: Fortis Clinical Research Limited, Sunflag Hospital Research Centre. Sector-16-A, Faridabad, Haryana-121002.
Contact: Ph-0129-4090-900; email-bd@fortis-cro.com.
Le vécu du patient parkinsonien ayant bénéficié d'une greffe intra-cérébrale d'embryons humains LOPES Manuel RESUME La greffe cérébrale de cellules embryonnaires dans la maladie de Parkinson à un stade évolué, est une approche thérapeutique innovante et prometteuse, mais au demeurant hasardeuse car elle risque d' occulter le patient au bénéfice d' une étude spécifique de la
HMP LEEDS INTEGRATED DRUG TREATMENT SYSTEM NEEDS ASSESSMENT OF TREATMENT DEMAND Author: Lydia Mwanje (Commissioning Support Officer) Safer Leeds Commissioning Team Whilst every care has been taken to ensure the accuracy of the data, it is supplied on the condition that employees of Leeds City Council and Leeds Primary Care Trust cannot be held responsible for any error, o